UBS Group AG
- SEC CIK
- 0001610520
- Latest filing
- Aug 13, 2026
ESLAW holding history
Estrella Immunopharma, Inc. in every 13F filed by UBS Group AG, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
ESLAW overviewAll 13F holders of ESLAWFull Q2 2026 holdings
- Shares (Q4 2025)
- 0
- Sold out in Q4 2025
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 4
- Since Q2 2024
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q4 2025 | 0 | $0 | 0.0% | −1,285−100.0% | Sold out | Holders |
| Q3 2025 | 1,285 | $67 | <0.1% | −47−3.5% | Reduced | Holders |
| Q2 2025 | 1,332 | $47 | <0.1% | −3,121−70.1% | Reduced | Holders |
| Q1 2025 | 4,453 | $343 | <0.1% | +4,453 | New | Holders |
| Q3 2024 | 0 | $0 | 0.0% | −5,090−100.0% | Sold out | Holders |
| Q2 2024 | 5,090 | $183 | <0.1% | +5,090 | New | Holders |